Dhanvantri Jeevan Rekha Analysis

dividend

Pros

Cons

• Unable to calculate sustainability of dividends as Dhanvantri Jeevan Rekha has not reported any payouts.
• Unable to evaluate Dhanvantri Jeevan Rekha's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
• Unable to evaluate Dhanvantri Jeevan Rekha's dividend against the top 25% market benchmark as the company has not reported any payouts.

health

Pros

• Dhanvantri Jeevan Rekha has been profitable on average in the past, therefore cash runway is not a concern.
• Dhanvantri Jeevan Rekha has been profitable on average in the past, therefore cash runway is not a concern.
• Debt is well covered by operating cash flow (1328.9%, greater than 20% of total debt).
• Debt is covered by short term assets, assets are 20.3x debt.
• Dhanvantri Jeevan Rekha's cash and other short term assets cover its long term commitments.
• The level of debt compared to net worth has been reduced over the past 5 years (7% vs 1% today).
• Dhanvantri Jeevan Rekha's level of debt (1%) compared to net worth is satisfactory (less than 40%).

Cons

• Dhanvantri Jeevan Rekha's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
• High level of physical assets or inventory.

management

Pros

• The average tenure for the Dhanvantri Jeevan Rekha board of directors is over 10 years, this suggests they are a seasoned and experienced board.
• Varinder's remuneration is lower than average for companies of similar size in India.
• Varinder's compensation has been consistent with company performance over the past year, both up more than 20%.

Cons

misc

Pros

Cons

• Dhanvantri Jeevan Rekha is not covered by any analysts.
• Dhanvantri Jeevan Rekha has significant price volatility in the past 3 months.

past

Pros

Cons

• Unable to compare Dhanvantri Jeevan Rekha's 1-year earnings growth to the 5-year average as it is not currently profitable.
• Dhanvantri Jeevan Rekha does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
• It is difficult to establish if Dhanvantri Jeevan Rekha has efficiently used its assets last year compared to the IN Healthcare industry average (Return on Assets) as it is loss-making.
• It is difficult to establish if Dhanvantri Jeevan Rekha improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
• It is difficult to establish if Dhanvantri Jeevan Rekha has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
• Unable to compare Dhanvantri Jeevan Rekha's 1-year growth to the IN Healthcare industry average as it is not currently profitable.

value

Pros

• Dhanvantri Jeevan Rekha is good value based on assets compared to the IN Healthcare industry average.
• BSE:531043 is up 58.5% outperforming the Healthcare industry which returned 5.4% over the past month.
• BSE:531043 is up 58.5% outperforming the market in India which returned 8% over the past month.

Cons

• Dhanvantri Jeevan Rekha is loss making, we can't compare its value to the IN Healthcare industry average.
• Dhanvantri Jeevan Rekha is loss making, we can't compare the value of its earnings to the India market.
• 531043 underperformed the Healthcare industry which returned 9.1% over the past year.
• 531043 underperformed the Market in India which returned -14.5% over the past year.